Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Mar 10, 2024 (filed on Mar 12, 2024)Insider Name:Sun Kevin MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-445Price:$0.70
-
Mar 05, 2024 (filed on Mar 07, 2024)Insider Name:Akhavan RaminOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,989Price:$0.88
-
Mar 05, 2024 (filed on Mar 07, 2024)Insider Name:Akhavan RaminOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,758Price:$0.88
-
Mar 05, 2024 (filed on Mar 07, 2024)Insider Name:Sun Kevin MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-2,531Price:$0.88
-
Mar 05, 2024 (filed on Mar 07, 2024)Insider Name:Sun Kevin MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-2,237Price:$0.88
-
Mar 05, 2024 (filed on Mar 07, 2024)Insider Name:Sun Kevin MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-180Price:$0.88
-
Jan 05, 2024 (filed on Jan 09, 2024)Insider Name:Akhavan RaminOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-3,202Price:$1.50
-
Dec 11, 2023 (filed on Dec 11, 2023)Insider Name:Sun Kevin MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-447Price:$1.45
-
Dec 11, 2023 (filed on Dec 11, 2023)Insider Name:Ibarra ClaudiaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-331Price:$1.45
-
Dec 08, 2023 (filed on Dec 11, 2023)Insider Name:Ibarra ClaudiaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-2,607Price:$1.41
Filings by filing date
-
Mar 10, 2024 (filed on Mar 12, 2024)Insider Name:Sun Kevin MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-445Price:$0.70
-
Mar 05, 2024 (filed on Mar 07, 2024)Insider Name:Akhavan RaminOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,989Price:$0.88
-
Mar 05, 2024 (filed on Mar 07, 2024)Insider Name:Akhavan RaminOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,758Price:$0.88
-
Mar 05, 2024 (filed on Mar 07, 2024)Insider Name:Sun Kevin MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-2,531Price:$0.88
-
Mar 05, 2024 (filed on Mar 07, 2024)Insider Name:Sun Kevin MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-2,237Price:$0.88
-
Mar 05, 2024 (filed on Mar 07, 2024)Insider Name:Sun Kevin MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-180Price:$0.88
-
Jan 05, 2024 (filed on Jan 09, 2024)Insider Name:Akhavan RaminOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-3,202Price:$1.50
-
Dec 11, 2023 (filed on Dec 11, 2023)Insider Name:Sun Kevin MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-447Price:$1.45
-
Dec 07, 2023 (filed on Dec 11, 2023)Insider Name:Sun Kevin MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-2,543Price:$1.53
-
Dec 07, 2023 (filed on Dec 11, 2023)Insider Name:Sun Kevin MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-2,248Price:$1.53
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 12340 EL CAMINO REAL SAN DIEGO CA 92130 |
Tel: | N/A |
Website: | https://dermtech.com |
IR: | See website |
Key People | ||
Bret Christensen President, Chief Executive Officer, Director | Kevin M. Sun Chief Financial Officer, Treasurer, Secretary | Ray Akhavan Chief Compliance Officer, General Counsel | Mark Aguillard chief commercial officer |
Business Overview |
DermTech, Inc. is a molecular diagnostic company. The Company is engaged in developing and marketing non-invasive genomics tests to aid in the diagnosis and management of melanoma. Its technology enhances evaluation of lesions suspicious for melanoma using non-invasive sample collection and detecting genomic markers associated with melanoma to identify higher risk lesions or rule out melanoma with a 99% or higher negative predictive value (NPV). It offers DermTech Melanoma Test (the DMT), which is a non-invasive way to enhance evaluation of pigmented lesions suspicious for melanoma. Its genomics platform has been designed to work with its Smart Sticker, which provides an easy and non-invasive way to collect a skin sample, in contrast to the existing standard of care of using a scalpel to biopsy suspicious lesions. It also provides its research services and technology platform on a contract basis to pharmaceutical companies that use the technology to support their clinical trials. |
Financial Overview |
For the fiscal year ended 31 December 2023, DermTech Inc revenues increased 5% to $15.3M. Net loss decreased 14% to $100.9M. Revenues reflect PLA Test segment increase of 4% to $14.4M, Adhesive Patch kits segment increase from $152K to $592K. Lower net loss reflects Research and development - Balancing va decrease of 38% to $12.6M (expense), Interest income/(expense) - Balancin increase from $1.4M to $2.9M (income). |
Employees: | 206 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | N/A |
Annual revenue (TTM): | $15.30M as of Dec 31, 2023 |
EBITDA (TTM): | -$101.93M as of Dec 31, 2023 |
Net annual income (TTM): | -$100.89M as of Dec 31, 2023 |
Free cash flow (TTM): | -$77.88M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 69,148,120 as of Feb 23, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |